Cipla
Sweety Jimmy is a seasoned professional in the pharmaceutical industry with extensive experience at Cipla. Currently serving as the Senior Director and Head of Global Access Markets since April 2020, Sweety has previously held various positions including Director of Business Lead for Access Market and Associate Director of International Business, Access Market. Prior to joining Cipla, Sweety worked at cipla ltd from September 2005 to April 2018 as a Senior Business Development Manager and Export Executive. Sweety holds a Postgraduate Diploma in Business Administration with a focus on Marketing Management from Symbiosis Institute of Management Studies (2006-2008) and a Bachelor of Commerce degree in Accounts from the University of Mumbai (1999-2004).
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.